Driehaus Capital Management LLC X4 Pharmaceuticals, Inc Transaction History

Driehaus Capital Management LLC

  • $10.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$1.9 - $5.6 $960,928 - $2.83 Million
-505,752 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$4.53 - $6.45 $1.31 Million - $1.87 Million
-289,560 Reduced 36.41%
505,752 $2.68 Million
Q1 2021

May 17, 2021
BUY
$6.63 - $10.28 $5.27 Million - $8.18 Million
795,312 New
795,312 $6.85 Million

Others Institutions Holding XFOR

# of Institutions
105
Shares Held
100M
Call Options Held
213K
Put Options Held
50.6K
View Full List

About X4 Pharmaceuticals, Inc

XFOR Quotes by TradingView
  • Ticker XFOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,646,096
  • Market Cap $23.3M
  • Description
  • X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...
More about XFOR
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email